Cinclus Pharma

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

CINC

This company develops biopharmaceutical treatments for cardio-renal diseases, primarily for patients with hypertension and chronic kidney disease.

Rivus Pharmaceuticals

The company develops oral small-molecule medicines for patients with obesity and associated cardiometabolic diseases including heart failure and type 2 diabetes.

BiPER Therapeutics

This company develops small molecule drugs targeting the BiP protein to treat gastrointestinal cancers and other pathological conditions in humans.

Curileum

The company develops novel therapies and small molecule drugs to restore gastrointestinal tissue health for patients with bowel cancer and inflammatory bowel disease.

Epicyt Pharma

This company develops pharmaceutical treatments to restore intestinal calcium absorption for patients with osteoporosis or those who have undergone gastric bypass surgery.

Sitryx

This biopharmaceutical company develops oral small molecule medicines that target immune cell metabolism to treat patients with chronic autoimmune and inflammatory diseases.

Abivax

This biotechnology company develops an oral small molecule drug to treat patients suffering from chronic inflammatory diseases, including ulcerative colitis and Crohn’s disease.